Handmade quality · Free shipping over $75 · Explore the atelier

AZD5718 14821 Negative Symptoms and Cognitive Impairments

SKU: 37573547449

4.7
USD120.00 USD170.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 25 - Jul 30

Description

Negative Symptoms and Cognitive Impairments Associated with Schizophrenia

Osuntokun W

InChiKey: DFPAKSUCGFBDDF-UHFFFAOYSA-N

Chemical Name: platinum(2+) cyclobutane-1

Smiles: O=C(C1C=C2C=CN(C2=CC=1)C1C=CC(F)=CC=1)N1CC(C1)N1CCN(CC1)C(=O)C1=NC=CS1

AZD5718 14821 Negative Symptoms and Cognitive ImpairmentsAZD5718 is an orally active inhibitor of FLAP (5Lipoxygenase activating protein), with an IC50 of 2 nM. AZD5718 is used in the study for coronary artery disease. Product information CAS Number: 2041075 86 7 Molecular Weight: 446. 50 Formula: C24H26N6O3 Chemical Name: (1R,2R) 2 [4 (5 methyl 1H pyrazol 3 yl)benzoyl] N {4 oxo 4H,5H,6H,7H pyrazolo[1,5 a]pyrazin 3 yl}cyclohexane 1 carboxamide Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products